SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-025075
Filing Date
2022-11-14
Accepted
2022-11-14 17:22:02
Documents
3
Period of Report
2022-12-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A crbp_def_14a_2022_11_14.htm DEF 14A 277844
2 GRAPHIC img153216094_0.jpg GRAPHIC 46905
3 GRAPHIC img153216094_1.jpg GRAPHIC 54159
  Complete submission text file 0000950170-22-025075.txt   418382
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37348 | Film No.: 221387865
SIC: 2834 Pharmaceutical Preparations